YOLFTbeta
Huaren Pharmaceutical Co Ltd

Huaren Pharmaceutical Co Ltd

300110 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

2.61CNY-0.07 (-2.61%)

Price History

Full chart

Market Stats

Previous Close2.68
Open2.67
Day Range2.60 – 2.68
52-Week Range2.41 – 3.98
Volume33.75M
Market Cap3.75B
P/E (TTM)0.00
Forward P/E23.47
EPS-0.40
Dividend Yield0.00%
Beta0.28
50-Day Avg2.89
200-Day Avg3.02

About

Huaren Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medicines and medical equipment in China and internationally. It offers nephrology products, including peritoneal dialysate, hemofiltration replacement fluid, and hemofiltration basic solution; respiratory products, such as doxofylline, levofloxacin hydrochloride, and composite potassium hydrogen phosphate injections; caffeine citrate injection; and bulk preparations comprising sodium chloride, glucose, glucose and sodium chloride, compound sodium chloride, sodium lactate ringer's, and compound electrolyte injections, as well as sterile water for injection and rinsing liquid products. The company also provides therapeutic infusion, which includes blood volume expander, haemostatic, nervous system, circulatory system, anti-infectives, anti-hepatitis and hepatitis adjuvant drugs, antineoplastic and adjuvant drugs, and glucose metabolism; and rubber stoppers. In addition, it is involved in software development; investment management; and construction. The company was founded in 1998 and is based in Qingdao, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Liping Han
  • Employees2.55K
  • HeadquartersNo. 187, Zhuzhou Road, Qingdao, China, 266101, China
  • Websitehttps://www.qdhuaren.com

Leadership

  • Ms. Liping HanVP & CFO · b. 1985
  • Mr. Xinguang FengVP & Secretary to the Board of Directors · b. 1985
  • Mr. Junhong WangVice President · b. 1977

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue161.14M207.57M288.55M338.30M405.31M562.03M867.20M916.76M1.11B1.25B1.31B1.38B1.46B1.32B1.56B1.62B1.64B1.35B1.32B
Growth (%)-+28.81%+39.01%+17.24%+19.81%+38.67%+54.30%+5.72%+20.63%+12.94%+5.04%+5.49%+5.64%-9.94%+18.55%+3.76%+1.04%-17.30%-2.34%
Cost of Revenue87.65M97.55M123.92M146.87M177.25M246.41M407.02M477.61M614.99M691.31M617.76M589.86M641.72M762.06M800.71M923.59M940.42M885.61M831.92M
Gross Profit73.49M110.02M164.62M191.44M228.06M315.63M460.18M439.15M490.90M557.67M694.12M794.00M820.22M554.53M760.15M695.90M695.83M467.55M489.54M
Gross Margin45.60%53.00%57.05%56.59%56.27%56.16%53.06%47.90%44.39%44.65%52.91%57.38%56.10%42.12%48.70%42.97%42.53%34.55%37.05%
Operating Expense36.72M55.73M89.84M107.36M132.82M202.99M317.36M374.08M468.25M525.43M630.30M746.21M746.18M440.49M608.84M497.41M469.89M1.82B321.63M
Operating Income36.76M54.29M74.79M84.07M95.24M112.64M142.82M65.07M22.66M32.24M63.82M47.79M74.04M114.04M151.30M198.49M225.94M-1.35B167.91M
Operating Margin22.82%26.16%25.92%24.85%23.50%20.04%16.47%7.10%2.05%2.58%4.87%3.45%5.06%8.66%9.69%12.26%13.81%-99.99%12.71%
EBITDA53.21M77.40M96.01M123.53M138.78M160.02M252.72M200.64M200.29M210.37M228.86M200.28M206.11M236.04M347.79M424.83M422.15M-1.18B-308.50M
EBITDA Margin33.02%37.29%33.27%36.51%34.24%28.47%29.14%21.89%18.11%16.84%17.44%14.47%14.10%17.93%22.28%26.23%25.80%-87.47%-23.35%
Net Income34.14M46.43M60.77M76.32M87.56M96.59M121.52M56.15M22.94M23.95M37.54M38.79M42.07M94.62M130.40M180.78M188.06M-1.37B-462.90M
Net Income Margin21.19%22.37%21.06%22.56%21.60%17.19%14.01%6.13%2.07%1.92%2.86%2.80%2.88%7.19%8.35%11.16%11.49%-101.13%-35.03%
R&D---7.00M12.82M20.12M40.88M46.19M53.50M52.80M48.58M56.02M62.43M55.22M63.68M55.30M68.68M72.29M67.83M
R&D as % of Total Revenue---2.07%3.16%3.58%4.71%5.04%4.84%4.23%3.70%4.05%4.27%4.19%4.08%3.41%4.20%5.34%5.13%
Interest Expense9.09M8.79M12.41M12.88M2.09M7.52M23.73M39.64M61.26M60.01M52.53M40.37M22.46M10.96M63.14M70.38M65.74M55.92M41.97M
Interest Expense % of Total Revenue5.64%4.24%4.30%3.81%0.52%1.34%2.74%4.32%5.54%4.80%4.00%2.92%1.54%0.83%4.05%4.35%4.02%4.13%3.18%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets362.18M507.33M635.78M1.15B1.25B1.78B2.37B2.62B2.75B2.72B2.89B3.15B2.71B3.42B5.64B5.16B5.17B3.43B2.70B
Total Liabilities177.50M286.30M321.98M47.60M55.77M445.69M907.56M1.14B1.31B1.20B1.34B897.11M461.81M1.09B3.20B2.56B2.40B2.05B1.79B
Total Equity184.68M221.03M313.80M1.10B1.19B1.29B1.46B1.48B1.44B1.46B1.49B2.18B2.18B2.26B2.37B2.53B2.69B1.30B837.89M
Cash13.44M48.55M27.78M471.26M305.80M120.65M362.88M204.90M144.79M30.16M149.02M617.24M378.91M228.67M417.15M221.71M232.04M163.81M138.97M
Total Debt134.70M249.00M270.00M--225.00M665.00M847.56M1.03B858.05M966.65M717.00M201.70M536.65M2.03B1.92B1.46B888.49M-
Net Debt121.26M200.45M242.22M-471.26M-305.80M104.35M302.12M642.66M888.55M827.89M817.63M99.76M-177.21M307.98M1.61B1.70B1.23B724.68M461.67M

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow7.66M57.24M38.63M77.61M59.53M99.44M39.78M65.56M18.77M181.65M211.08M254.32M309.33M-10.74M-578.52M217.98M305.60M322.36M390.23M
Investing Cash Flow-8.77M-140.73M-96.55M-66.61M-222.76M-353.33M-285.89M-228.07M-156.33M-168.21M-95.84M-55.18M5.47M-237.97M-458.58M-143.81M-97.14M-37.92M-
Financing Cash Flow2.88M118.59M37.16M432.64M-2.09M67.51M487.63M3.38M77.56M-127.85M2.95M270.38M-576.42M112.35M1.04B-152.67M-120.72M-369.50M-
Capital Expenditure8.86M130.82M97.25M67.10M232.83M270.43M227.69M259.80M156.73M168.95M87.36M45.47M32.02M57.96M27.86M42.33M45.86M24.69M48.98M
Free Cash Flow-1.20M-73.58M-58.62M10.51M-173.29M-170.99M-187.92M-194.24M-137.97M12.70M123.72M208.84M277.31M-68.71M-606.38M175.65M259.74M297.67M341.25M
Dividends Paid8.99M11.24M15.84M12.52M2.09M7.52M23.73M87.06M86.99M50.45M49.93M55.56M35.46M11.82M17.73M21.27M86.15M78.90M42.46M
FCF to OCF-15.63%-128.54%-151.75%13.54%-291.10%-171.94%-472.40%-296.27%-735.16%6.99%58.61%82.12%89.65%639.63%104.82%80.58%84.99%92.34%87.45%
Dividend Paid to FCF-750.75%-15.27%-27.02%119.15%-1.21%-4.40%-12.63%-44.82%-63.05%397.28%40.36%26.60%12.79%-17.21%-2.92%12.11%33.17%26.50%12.44%

Earnings

Report DateSep 30, 2010Dec 31, 2010Mar 31, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Oct 23, 2014Mar 1, 2015Apr 18, 2015Aug 19, 2015Oct 25, 2015Feb 25, 2016Apr 25, 2016Jul 11, 2016Oct 27, 2016Feb 28, 2017Apr 21, 2017Aug 30, 2017Oct 18, 2017Apr 26, 2018Jul 27, 2018Oct 26, 2018Apr 19, 2019Aug 30, 2019Oct 26, 2019Apr 22, 2020Aug 14, 2020Oct 27, 2020Mar 20, 2021Apr 23, 2021Aug 21, 2021Oct 28, 2021Apr 22, 2022Aug 20, 2022Oct 21, 2022Mar 25, 2023Apr 20, 2023Aug 26, 2023Oct 25, 2023May 16, 2024Aug 30, 2024Oct 29, 2024May 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------0.120.12-0.070.050.01--0.000.01--------------------------------
EPS Actual0.020.040.020.020.020.030.020.020.020.020.020.020.030.030.020.000.040.010.010.010.01-0.010.000.000.010.010.000.000.010.000.010.010.010.010.010.010.020.020.030.020.040.040.020.040.040.050.030.030.050.040.020.020.010.020.01-0.440.010.01
Surprise-----------------66.67%-91.67%--85.71%-80.00%-200.00%---0.00%--------------------------------
Timing----------------Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours---------Pre-market------After-hours--After-hours-----

Key Statistics & Ratios

Market Cap3.75B
Enterprise Value5.38B
Trailing P/E0.00
Forward P/E23.47
PEG Ratio0.00
Price / Sales2.88
Price / Book4.98
EPS-0.40
Book Value0.733
Revenue (TTM)1.30B
Gross Profit (TTM)415.77M
EBITDA218.27M
Profit Margin-36.21%
Operating Margin8.87%
Return on Equity-39.80%
Return on Assets2.27%
Shares Outstanding1.18B
Shares Float885.28M
Beta0.28
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.02Jul 10, 2024
20231×
0.02Jul 12, 2023
20221×
0.02Jun 17, 2022
20211×
0.01Jun 4, 2021
20201×
0.01May 19, 2020
20191×
0.03Jul 11, 2019
20181×
0.02May 22, 2018
20172×
0.01Nov 1, 20170.01May 31, 2017
20151×
0.03Jul 1, 2015
20141×
0.06May 7, 2014
20121×
0.04May 30, 2012

Stock Splits

  • May 31, 201715:10
  • May 7, 201415:10
  • May 16, 201320:10